The South African Health Products Regulatory Authority has reported a second death following vaccination with the Johnson & Johnson COVID-19 vaccine.
According to Sahpra, Guillain-Barré syndrome (GBS) is a rare but potentially severe neurological adverse event that is associated with the administration of various vaccines and other medicines.
In August, the country recorded its first fatality linked to taking the jab.
The second fatality, which was reported last month, was investigated by the National Immunisation Safety Expert Committee.
It found the patient’s demise as a result of GBS can be tied to taking the Johnson & Johnson vaccine.
In many cases, the condition resolves with no serious after-effects, but in some severe instances, it can cause serious or life-threatening problems.
More Stories
CoCT Plans To Shield Capetonians From Power Cuts Within 3 Years – Hill-Lewis
Modernise Basic Education System – Ramaphosa
New Johannesburg Mayor To Be Elected On Friday
Unions Reveal Culture Of Fear At Eskom
Ramaphosa Set To Provide Recovery Plan For Basic Education Sector
Not Implementing Eskom Tariff Hike Could Be Disastrous – Experts
Tshwane Owes Eskom R1.4bn
Eskom Announces Stage 5 Blackouts
Coalition Files Court Papers To Set Aside Nersa’s Eskom Tariff Approval
Public Protector Completes Onvestigation On Phala Phala
Nelson Mandela Bay Dams Dries Up
Energy Crisis Committee Releases Update On Action Plan